B. Riley Wealth Advisors Inc. Has $15.89 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

B. Riley Wealth Advisors Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 31,405 shares of the healthcare conglomerate's stock after selling 6,820 shares during the quarter. UnitedHealth Group accounts for about 0.5% of B. Riley Wealth Advisors Inc.'s investment portfolio, making the stock its 28th largest position. B. Riley Wealth Advisors Inc.'s holdings in UnitedHealth Group were worth $15,886,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Armis Advisers LLC purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $282,000. Polar Asset Management Partners Inc. purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $1,973,000. Garde Capital Inc. grew its position in UnitedHealth Group by 17.1% during the 4th quarter. Garde Capital Inc. now owns 616 shares of the healthcare conglomerate's stock worth $312,000 after purchasing an additional 90 shares in the last quarter. Hall Capital Management Co. Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $2,351,000. Finally, Liberty Square Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $221,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 over the last three months. 0.33% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research note on Monday, May 19th. Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. KeyCorp reduced their price objective on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $0.58 during trading hours on Tuesday, hitting $294.99. 20,069,744 shares of the stock were exchanged, compared to its average volume of 6,655,522. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $267.60 billion, a P/E ratio of 19.03, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The business's 50-day moving average is $448.25 and its two-hundred day moving average is $501.48.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the company posted $6.91 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.